Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

Anti-androgens regulate amino acid-mTORC1 signalling and extracellular vesicle secretion to modulate prostate cancer progression

McCormick K. et al, (2019), CLINICAL & EXPERIMENTAL METASTASIS, 36, 167 - 167

Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database

Bryant RJ. et al, (2019), Journal of Clinical Urology

An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells.

Freedman JD. et al, (2018), Cancer Res, 78, 6852 - 6865

Comparison of prostate biopsy with or without pre-biopsy multi-parametric MRI in prostate cancer detection: an observational cohort study.

Bryant RJ. et al, (2018), J Urol

Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis.

Philippou Y. et al, (2018), BJU Int

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage.

Aleksic T. et al, (2018), Cancer Res, 78, 3497 - 3509

VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer.

Redchenko I. et al, (2018), JOURNAL OF CLINICAL ONCOLOGY, 36

First Report of Prostate-specific Membrane Antigen-targeted Immunotherapy in Prostate Cancer: The Future is Bright.

Lamb AD. et al, (2018), Eur Urol, 73, 653 - 655

Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?

Bryant RJ. et al, (2018), BJU Int

The management of non-muscle-invasive bladder cancer: A comparison of European and UK guidelines

Leiblich A. et al, (2018), Journal of Clinical Urology, 11, 144 - 148

Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.

Gonnissen A. et al, (2018), Am J Pathol, 188, 795 - 804

Diagnostic Pathways for Screen-detected Prostate Cancer: The Plot Thickens.

Hamdy FC. et al, (2017), Eur Urol

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.

Aleksic T. et al, (2017), Br J Cancer, 117, 1600 - 1606

Orient Expression: Solving the Mystery of Asian Prostate Cancer?

Lamb AD. et al, (2017), Eur Urol

Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer.

Gonnissen A. et al, (2017), BMC Cancer, 17

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.

Pirovano G. et al, (2017), Br J Cancer, 117, 503 - 512

The drebrin/EB3 pathway drives invasive activity in prostate cancer.

Dart AE. et al, (2017), Oncogene, 36, 4111 - 4123

Novel biomarkers for the detection of prostate cancer.

Jakobsen NA. et al, (2016), J Clin Urol, 9, 3 - 10

Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.

Verrill C. et al, (2016), Oncotarget, 7, 1107 - 1119

Load More

Include forthcoming?